- Home
- ICCM vs TOI Comparison
ICCM vs TOI Comparison
Compare ICCM & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- TOI
- Stock Information
- Founded
- ICCM 2006
- TOI 2007
- Country
- ICCM Israel
- TOI United States
- Employees
- ICCM N/A
- TOI N/A
- Industry
- ICCM
- TOI Medical/Nursing Services
- Sector
- ICCM
- TOI Health Care
- Exchange
- ICCM Nasdaq
- TOI Nasdaq
- Market Cap
- ICCM 29.3M
- TOI 22.7M
- IPO Year
- ICCM N/A
- TOI N/A
- Fundamental
- Price
- ICCM $0.58
- TOI $0.36
- Analyst Decision
- ICCM Strong Buy
- TOI Strong Buy
- Analyst Count
- ICCM 2
- TOI 1
- Target Price
- ICCM $2.70
- TOI $2.50
- AVG Volume (30 Days)
- ICCM 411.6K
- TOI 62.9K
- Earning Date
- ICCM 11-13-2024
- TOI 11-06-2024
- Dividend Yield
- ICCM N/A
- TOI N/A
- EPS Growth
- ICCM N/A
- TOI N/A
- EPS
- ICCM N/A
- TOI N/A
- Revenue
- ICCM $3,336,000.00
- TOI $361,067,000.00
- Revenue This Year
- ICCM $18.61
- TOI $29.17
- Revenue Next Year
- ICCM $54.91
- TOI $16.43
- P/E Ratio
- ICCM N/A
- TOI N/A
- Revenue Growth
- ICCM 3.60
- TOI 23.31
- 52 Week Low
- ICCM $0.48
- TOI $0.27
- 52 Week High
- ICCM $1.57
- TOI $2.66
- Technical
- Relative Strength Index (RSI)
- ICCM 45.18
- TOI 60.57
- Support Level
- ICCM $0.51
- TOI $0.32
- Resistance Level
- ICCM $0.61
- TOI $0.39
- Average True Range (ATR)
- ICCM 0.04
- TOI 0.02
- MACD
- ICCM -0.00
- TOI 0.01
- Stochastic Oscillator
- ICCM 64.19
- TOI 63.51
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.